Participation in medical studies

The tre­at­ment results for mali­gnant tumors have impro­ved con­si­der­ab­ly in recent years. Cli­ni­cal stu­dies are a pre­re­qui­si­te for new drug approval.

In addi­ti­on to the com­mon tre­at­ment methods with appro­ved drugs and gui­de­li­ne-based the­ra­py con­cepts, pati­ents have the oppor­tu­ni­ty to take part in cli­ni­cal stu­dies. Cli­ni­cal tri­als are impe­ra­ti­ve to advan­ce can­cer tre­at­ment. They are also essen­ti­al in order to be able to deve­lop the best and most effec­ti­ve the­ra­py stra­te­gies for pati­ents. Par­ti­ci­pa­ti­on in cli­ni­cal stu­dies can be an advan­ta­ge (qua­li­ty fea­ture & pro­gno­sis fac­tor). Talk to your trea­ting doc­tor about cur­rent stu­dies in your indi­vi­du­al case!

Advantages of participating in a study

• even more inten­si­ve care and monitoring
• d. R. Tre­at­ment accord­ing to the latest the­ra­py concepts
• important con­tri­bu­ti­on to other women and sci­ence. Becau­se the more exten­si­ve the data, the hig­her the infor­ma­ti­on con­tent and gain of know­ledge of the stu­dy and the sub­se­quent opti­miz­a­ti­on of the therapy.

Reasons against participating in the study

Rea­sons for not par­ti­ci­pa­ting in the stu­dy can be the inclu­si­on and exclu­si­on cri­te­ria spe­ci­fied in the stu­dy pro­to­col. The­se ser­ve to pre­cise­ly deli­mit the pati­ent group invol­ved and also as a safe­ty mea­su­re for the pati­ent. Par­ti­ci­pa­ti­on in the stu­dy can be exclu­ded if cer­tain comor­bi­di­ties are present.

Rights and obligations that you should consider when participating in a study

Rights

In accordance with the sta­tu­to­ry pro­vi­si­ons, pati­ents are insu­red against pos­si­ble health dis­or­ders cau­sed by the the­ra­py during the cli­ni­cal tri­al. This inclu­des ade­qua­te tre­at­ment of the health disorders.

Obli­ga­ti­ons (to obtain insuran­ce cover)

Other medi­cal tre­at­ments may only be given with the con­sent of the inves­ti­ga­tor (except in emer­gen­ci­es). In the event of dama­ge to health, all appro­pria­te mea­su­res must be taken to cla­ri­fy the cau­se and extent and to redu­ce the dama­ge. At the request of the pati­ent insu­rer, the trea­ting phy­si­ci­ans, health insu­rers or social insu­rers can be com­mis­sio­ned to pre­pa­re reports on the dama­ge to health and also to aut­ho­ri­ze them to pro­vi­de information.

What happens to my personal data?

Per­so­nal data and infor­ma­ti­on from your medi­cal records pro­vi­de infor­ma­ti­on about the cour­se of the dise­a­se and cer­tain test results. The­se are recor­ded in pseud­ony­mi­zed form as part of the sci­en­ti­fic inves­ti­ga­ti­on and eva­lua­ted in com­pli­an­ce with the strict data pro­tec­tion laws.

Can I withdraw my participation in the study?

You can revo­ke your par­ti­ci­pa­ti­on in the stu­dy at any time, as par­ti­ci­pa­ti­on in the stu­dy is a vol­un­ta­ry and indi­vi­du­al decisi­on and remains so even after you have given your con­sent. You do not have to fear any tre­at­ment dis­ad­van­ta­ges if you dis­con­ti­nue your studies.

Source:

https://studienportal-eierstockkrebs.de/vorteile-einer-studienteilnahme/